4//SEC Filing
Deignan Charles A. 4
Accession 0001209191-21-057457
CIK 0001539029other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 5:12 PM ET
Size
5.1 KB
Accession
0001209191-21-057457
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Sale
Common Stock
2021-09-21$6.41/sh−2,800$17,948→ 316,449 total
Footnotes (1)
- [F1]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
Documents
Issuer
Clearside Biomedical, Inc.
CIK 0001539029
Entity typeother
Related Parties
1- filerCIK 0001664690
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 5:12 PM ET
- Size
- 5.1 KB